Infecção do Sítio Cirúrgico após cirurgias com implante de próteses ortopédicas
DOI:
https://doi.org/10.33233/eb.v17i2.979Resumo
As Infecções de Sítio Cirúrgico (ISC) representam uma das principais complicações entre os pacientes submetidos a cirurgias, destacando-se as ocorridas em cirurgias ortopédicas dependentes de implantes, que comumente se manifestam após a alta hospitalar, portanto a vigilância destes pacientes após alta é essencial para detecção precoce da ISC. Objetivo: objetivou-se identificar o intervalo de tempo entre a realização da cirurgia e a manifestação das ISC de tais pacientes. Método: Realizou-se uma revisão integrativa da literatura, que utilizou artigos selecionados nas bases de dados da Pubmed, Science Direct, e Scopus. Resultados: Identificou-se o tempo de manifestação da ISC em 30 dias, sendo a infecção de órgão/cavidade a de maior incidência (57,9%); o método de vigilância predominante nos estudos analisados foram ligações telefônicas (57,8%); e a vigilância por 30 dias foi descrito em 41,7% desses. Conclusão: Verificou-se assim que a mudança dos critérios proposta pelo NHSN/CDC para vigilância após a alta hospitalar, de 30 a 90 dias se justifica diante do tempo de manifestação da ISC predominante nos estudos analisados.
Palavras-chave: cirurgia, infecção hospitalar, prevenção e controle, ortopedia.
Referências
Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Critérios Diagnósticos de infecção relacionada à assistência a saúde. Série: Segurança do paciente e qualidade nos serviços de saúde. Livro 2. Anvisa; 2013. p.84.
Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumiaty G, Kainer MA, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med Overseas 2014;13:1198-208.
Greene LR. Guide to the elimination of orthopedic surgery surgical site infections: An executive summary of the association for professionals in infection control and epidemiology elimination guide. Am J Infect Control 2012;40:384-6.
Kapadia BH, McElroy MJ, Issa M, Johnson AJ, Bozic KJ, Mont MA. the economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty 2014;29:929-32.
OMS. Organização Mundial da Saúde. Aliança mundial para segurança do paciente. Cirurgias seguras salvam vidas. OMS; 2009. [citado 2016 Dez 10]. DisponÃvel em: http://bvsms.saude.gov.br/bvs/publicacoes/seguranca_paciente_cirurgias_seguras_salvam_vidas.pdf
NICE. National Institute for Health and Clinical Excellence. Surgical site infection prevention and treatment of surgical site infection. London: RCOG Press; 2008.
CDC. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN). Surgical Site Infection (SSI) Event. 2015.
Mendes KDS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm 2008;17:758-64.
Stetler CB, Morsi D, Rucki S, Broughton S, Corrigan B, Fitzgerald J, et al. Utilization focused integrative reviews in a nursing service. Appl Nurs Res 1998;11:195-206.
Jaen F, Gallardo SMI, Arrazola MP, Codes GA, Juanes A, Resines C. Multicentre study of infection incidence in knee prosthesis. Rev Esp Cir Ortop Traumatol 2012; 56:38-45.
Sullivan C, McNeish J, Mullings A, Reilly J. Surgical site infection surveillance: a Scottish perspective (2003–2010). J Infect Prev 2013;14:20-25.
Contreras JL, Limón E, Matas L, Olona M, Sallés M, Pujol M. Epidemiology of surgical site infections after total hip and knee joint replacement during 2007-2009: a report from the VINCat Program. Enferm Infecc Microbiol Clin 2012;30:26-32.
Carneiro M, Krummenauer EC, Machado JAA, Adam MS, Souza JG, Gonçalves RA. Incidence of infection in orthopedic surgeries: Do we actually know it? Am J Infect Control 2014;42:461-4.
Inacio MCS, Silverstein DK, Raman R, Macera CA, Nichols JF, Shaffer RA, Fithian DC. The impact of pre-operative weight loss on incidence of surgical site infection and readmission rates after total joint arthroplasty. J Arthroplasty 2014;29:458-64.
Saucedo JM, Marecek GS, Wanke TR, Lee J, Stulberg SD, Puri L. Understanding readmission after primary total hip and knee arthroplasty: Who’s at risk? J Arthroplasty 2014;29:256-60.
Kheir MM, Clement C, Derman PB, Flynn DN, Speck RM, Levin LS, et al. Are there identifiable risk factors and causes associated with unplanned readmissions following total knee arthroplasty? J Arthroplasty 2014;29:2192-96.
Pinto CZS, Alpendre FT, Stier CJN, Maziero ECS, Alencar PGC, Cruz EDA. Characterization of hip and knee arthroplasties and factors associated with infection. Rev Bras Ortop 2015;50:694-99.
Maslow J, Hutzler L, Slover J, Bosco J. Etiology of readmissions following orthopaedic procedures and medical admissions. A Comparative Analysis. Bull Hosp Jt Dis 2015;73:269-75.
Lower HE, Dale H, Eriksen HM, Aavitsland P, Skjeldestad FE. Surgical site infections after hip arthroplasty in Norway, 2005-2011: Influence of duration and intensity of postdischarge surveillance. Am J Infect Control 2015;43:323-28.
Bini SA, Inacio MCS, Cafri G. Two-day length of stay is not inferior to 3 days in total knee arthroplasty with regards to 30-day readmissions. J Arthroplasty 2015;30:733-8.
Belmont PJ, Goodman GP, Rodriguez M, Bader JO, Waterman BR, Schoenfeld AJ. Predictors of hospital readmission following revision total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2015:1-10.
Meur NL, Guillon LG, Wang S, Astagneau P. Health insurance database for post-discharge surveillance of surgical site infection following arthroplasty. J Hosp Infect 2016;92:140-46.
May ER, Bush K, Vickers D, Stephanie S. Use of a provincial surveillance system to characterize postoperative surgical site infections after primary hip and knee arthroplasty in Alberta, Canada. Am J Infect Control 2016:1-5.
Kurtz SM, Lau EC, Ong KL, Adler EM, Kolisek FR, Manley MT. Which hospital and clinical factors drive 30- and 90-day readmission after TKA? J Arthroplasty 2016:1-9.
Keswani A, Lovy AJ, Robinson J, Levy, R, Chen D, Moucha CS. Risk factors predict increased length of stay and readmission rates in revision joint arthroplasty. J Arthroplasty 2016;31:603-8.
Hart A, Antoniou J, Brin YS, Huk OL, Zukor DJ, Bergeron SG. Simultaneous bilateral versus unilateral total knee arthroplasty: A comparison of 30-day readmission rates and major complications. J Arthroplasty 2016;31(1):31-5. http//doi: 10.1016/j.arth.2015.07.031
Keswani A, Weiser MC, Shin J, Lovy AJ, Moucha CS. Discharge destination after revision total joint arthroplasty: An analysis of post discharge outcomes and placement risk factors. J Arthroplasty 2016;31:1866-72.
Drager J, Hart A, Khalil JA, Zukor DJ, Bergeron SG, Antoniou J. Shorter hospital stay and lower 30-day readmission after unicondylar knee arthroplasty compared to total knee arthroplasty. J Arthroplasty 2016;31:356-61.
Yokoe DS, Avery TR, Platt R, Huang SS. Reporting surgical site infections following total hip and knee arthroplasty: Impact of limiting surveillance to the operative Hospital. Clin Infect Dis 2013; 9:1282–88.
Kinnula S, Renko M, Tapiainen T, Pokka T, Uhari M. Post-discharge follow-up of hospital-associated infections in paediatric patients with conventional questionnaires and electronic surveillance. J Hosp Infect 2012;80:13-16.
Tanner J, Khan, D, Aplin C, Ball J, Thomas M, Bankart J. Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J Hosp Infect 2009;72:243-50.
Park SJ, Lee KY, Park JW, Lee JG, Choi HJ, Chun HK, et al. A preliminary study for the development of indices and the current state of surgical site infections (SSIs) in Korea: the Korean Surgical Site Infection Surveillance (KOSSIS) program. Ann Surg Treat Res 2015;88:119-25.
Koek MB, Wille JC, Isken MR, Voss A, Benthem BH. Post-discharge surveillance (PDS) for surgical site infections: a good method is more important than a long duration. Euro Surveill 2015;20:1-11.
